Insider Selling: Phreesia, Inc. (NYSE:PHR) SVP Sells 11,853 Shares of Stock

Phreesia, Inc. (NYSE:PHR) SVP David Linetsky sold 11,853 shares of Phreesia stock in a transaction dated Wednesday, December 11th. The stock was sold at an average price of $24.85, for a total transaction of $294,547.05. Following the transaction, the senior vice president now directly owns 188,354 shares in the company, valued at $4,680,596.90. This trade represents a 5.92 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

David Linetsky also recently made the following trade(s):

• On Friday, October 18th, David Linetsky sold 1,100 shares of Phreesia stock. The shares were sold at an average price of $20.49, for a total transaction of $22,539.00.
• On Tuesday, October 15th, David Linetsky sold 2,011 shares of Phreesia stock. The stock was sold at an average price of $21.03, for a total value of $42,291.33.
• On Thursday, September 19th, David Linetsky sold 24 shares of Phreesia stock. The stock was sold at an average price of $24.04, for a total value of $576.96.
• On Tuesday, September 17th, David Linetsky sold 36 shares of Phreesia stock. The shares were sold at an average price of $24.77, for a total value of $891.72.

Phreesia Stock Up 1.6 %

Shares of PHR traded up $0.39 during midday trading on Friday, hitting $24.94. The company had a trading volume of 532,812 shares, compared to its average volume of 450,490. Phreesia, Inc. has a 1 year low of $17.07 and a 1 year high of $29.16. The firm has a market capitalization of $1.45 billion, a P/E ratio of -16.70 and a beta of 0.98. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.77 and a current ratio of 1.74. The company’s 50-day simple moving average is $20.39 and its 200-day simple moving average is $21.80.

Phreesia (NYSE:PHR) last posted its quarterly earnings results on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.04. The company had revenue of $106.80 million for the quarter, compared to analysts’ expectations of $106.33 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. Phreesia’s quarterly revenue was up 16.6% on a year-over-year basis. During the same period last year, the firm earned ($0.58) earnings per share. As a group, sell-side analysts expect that Phreesia, Inc. will post -1.22 EPS for the current year.

Analyst Ratings Changes

Several analysts recently issued reports on PHR shares. JPMorgan Chase & Co. boosted their price objective on shares of Phreesia from $27.00 to $28.00 and gave the company an “overweight” rating in a report on Monday, September 9th. Royal Bank of Canada restated a “sector perform” rating and issued a $23.00 price objective on shares of Phreesia in a report on Friday, September 27th. Truist Financial increased their price objective on shares of Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a research report on Wednesday. Needham & Company LLC reissued a “buy” rating and issued a $29.00 target price on shares of Phreesia in a research report on Tuesday. Finally, Robert W. Baird lowered their price target on Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a research report on Wednesday. One research analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $29.33.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. Versor Investments LP purchased a new stake in shares of Phreesia in the 3rd quarter valued at about $694,000. Zacks Investment Management acquired a new position in Phreesia during the third quarter worth approximately $631,000. Sei Investments Co. lifted its stake in Phreesia by 135.3% in the second quarter. Sei Investments Co. now owns 165,327 shares of the company’s stock valued at $3,505,000 after buying an additional 95,058 shares during the last quarter. Peregrine Capital Management LLC lifted its stake in Phreesia by 11.3% in the second quarter. Peregrine Capital Management LLC now owns 354,607 shares of the company’s stock valued at $7,518,000 after buying an additional 36,047 shares during the last quarter. Finally, Deerfield Management Company L.P. Series C acquired a new stake in shares of Phreesia in the second quarter valued at approximately $4,078,000. 92.10% of the stock is owned by hedge funds and other institutional investors.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.